Medication – Kepplah Sat, 25 Sep 2021 04:22:48 +0000 en-US hourly 1 Medication – Kepplah 32 32 EXPLANATION: Medical abortion becomes the last target of the GOP Fri, 24 Sep 2021 22:34:34 +0000

By IRIS SAMUELS Associated Press / Report for America

Medical abortion accounts for about 40% of all abortions in the United States. It is an option that has become important during the COVID-19 pandemic.

While Republican states strive to restrict access to abortion in general, many also limit access to medical abortions.

Providers say medical abortion is safe and essential, especially as access to clinics in Republican-controlled states becomes more difficult.

Medical abortion has been available in the United States since 2000, when the Food and Drug Administration approved the use of mifepristone.

A medical abortion involves taking mifepristone, waiting 24 to 48 hours, then taking misoprostol. Mifepristone blocks the hormone progesterone, which is essential for maintaining a pregnancy. Misoprostol empties the uterus causing cramping and bleeding.

The drugs are approved for use by the FDA up to 10 weeks gestation.
The method is considered by healthcare professionals to be very effective and safe, with terminations of pregnancy in over 95% of cases and serious complications in 0.4% of cases.

According to the FDA, 3.7 million women had medical abortion between 2000 and 2018. During this period, 24 women died after taking mifepristone.

The popularity of the method has continued to grow. The Guttmacher Institute, a research organization that supports the right to abortion, estimates that it accounts for about 40% of all abortions in the United States and 60% of those that take place up to 10 weeks gestation.

Abortion rights advocates say the pandemic has demonstrated the value of virtually provided medical care, including the privacy and convenience of abortion that takes place at a woman’s home, instead of a clinic .

Adding to its appeal: Clinics are rare in several states where Republicans have passed strict laws restricting access. Mississippi, Missouri, North Dakota, South Dakota, and West Virginia are states that only have one abortion clinic.

Abortion providers say that as access to clinics becomes more difficult, medical abortion can allow women to have an abortion without having to travel, which can be particularly difficult and costly for low-income women.

Opponents of abortion, fearing that medical abortion will become more prevalent, are pushing legislation in Republican-ruled states to limit access to drugs.

States have adopted several measures to limit its availability. These include banning the delivery of abortion pills by mail, shortening the 10-week window during which the method is allowed, and forcing women to take the pills at a clinic rather than at home.

Some states also require doctors to tell women who have medical abortions that the process can be reversed halfway, a claim according to critics that is unsupported by science.

In 33 states, only doctors are licensed to provide abortion pills. In 17 states and the District of Columbia, they can be delivered by advanced practice clinicians.

Clinicians providing the drug must be physically present when it is administered in 19 states, which means patients with abortions cannot take the drugs at home.

The Republican governors of Arkansas, Arizona, Montana, Oklahoma and Texas this year signed laws banning the delivery of abortion drugs by mail. These laws were widely seen as a response to the rise in popularity of telemedicine during the pandemic.

Laws face legal challenges in Montana and Oklahoma. In Ohio, a judge temporarily blocked a law that would have banned the use of telemedicine for abortion pills while a court challenge is pending.

Some Republican legislatures also impose limits on the time of pregnancy when medical abortion can be performed. In Indiana and Montana, laws passed this year ban the drug after 10 weeks gestation, and in Texas, a newly signed law bans the drug after seven weeks.

Texas law is expected to come into effect in December. It happened just as Texas began to ban almost all abortions under a more ambitious law, known as Senate Bill 8, which became the biggest curb on abortion in the world. country in half a century.

Eight states require counseling to promote the idea that medical abortion can be reversed with a high dose of progesterone after taking mifepristone.

The American College of Obstetricians and Gynecologists does not support the prescription of progesterone for this use and states that the reversal claim is not based on scientific evidence.

Such laws are in effect in Arkansas, Idaho, Kentucky, Louisiana, Nebraska, South Dakota, Utah, and West Virginia. Court cases in Indiana, North Dakota, Oklahoma and Tennessee have blocked enforcement of these counseling requirements. In Montana, the law is due to go into effect Oct. 1 but is being challenged in court.

At the onset of the coronavirus pandemic, the Food and Drug Administration – under a federal court order – relaxed restrictions on abortion pills so they could be mailed.

But the FDA and its parent health agency, under the Trump administration, then argued that the rules were necessary to ensure the pills were used safely. The rule requires patients to take the only mifepristone tablet in a hospital, clinic, or doctor’s office and sign a form with information about the drug’s potential risks.

The association of obstetricians and gynecologists has filed a lawsuit to overturn the rule, triggering a series of conflicting court rulings.

Last April, the FDA again asserted that women seeking an abortion pill would not be required to visit a doctor during the COVID-19 pandemic. The policy change only applies in states where there are no laws prohibiting the use of telemedicine or requiring the presence of a physician when medications are taken.

FDA policy also only applies for as long as the COVID-19 health emergency lasts. Several medical organizations are pushing for medical abortion to be permanently available through online prescription and mail order pharmacies.

Aid Access is one of several online initiatives that offer to mail abortion pills to women. It is headed by Dr Rebecca Gomperts, a Dutch doctor.

The FDA, then under the Trump administration, sent a letter to Aid Access over two years ago asking it to cease operations, but the online drug supplier continued to send abortion pills to female patients in the United States. United.

The legality of the practice is ambiguous, but groups such as Plan C, which aims to raise awareness about self-administered abortions, provide information on where and how the drugs can be obtained online.

These groups say such access is especially important for women in places where abortion clinics are constantly attacked by abortion advocates and where lawmakers and governors are making it progressively more difficult to maintain clinics.

If / When / How, a reproductive rights legal aid group, has followed 24 cases since 2000 when women were prosecuted for self-administered abortions.

“It is possible that someone will be targeted for investigation, arrest or prosecution, even in the absence of a law that makes it truly illegal,” said Sara Ainsworth, group policy director.

Source link

]]> 0
Analysis of Automated Drug Preparation System, Global Market Segment Trends 2020-2026 Fri, 24 Sep 2021 14:28:52 +0000

The Global Automated Drug Mixing System Market report provides an overview of the ongoing procedure within the Global Automated Drug Mixing System market. In addition, the report also takes into account the impact of the novel COVID-19 pandemic on the automated drug preparation system, the global market and offers a clear assessment of the projected fluctuations of the market during the forecast period. The various factors which are likely to impact the overall dynamics of the Automated Drug Delivery System, Global Market over the forecast period (2020-2025) including current trends, growth opportunities, limiting factors, etc. are discussed in detail in the market research.

The report gives an analysis of market size, trends, share, growth, cost structure and drivers. The Global Automated Drug Preparation System Market report, Global has studied key market opportunities and influencing factors that are useful and beneficial to the business. The report helps users analyze future demand and forecast exact implementation. The report explains current business and industrial developments, future policy changes, and opportunities available in the market. It gives a detailed summary of market trends, stocks and patterns of income and market value growth.

This report studies the Automated Drug Preparation System, global market status and outlook for global and major regions, from the perspective of players, countries, product types and end industries, this report analyzes major players in the Global Automated Drug Preparation System, global industry and broken down by product type and end applications / industries. This report also includes the impact of COVID-19 on the global Automated Drug Dispensing System industry.

Request a copy of this report @

Illumination of Automated Drug Preparation System Key Pointers, Global Market Report:

An in-depth study of the geographic landscape of Automated Drug Preparation System, Global Market:

  • The study broadly illustrates the regional hierarchy of this industry, while bifurcating it between the United States, China, Europe, Japan, Southeast Asia and India.
  • The report provides information regarding the market share held by each country as well as potential growth drivers according to geographic analysis.
  • The research report estimates the growth rate that each region would cover over the forecast period.

Competitive landscape

The section on competitive landscape offers valuable insight into the business outlook of major market players operating in the Automated Drug Preparation System, global market. The market share, product portfolio, pricing strategy and growth strategies adopted by each market player are included in the report. The main actions taken by key players to address the business challenges highlighted by the novel COVID-19 pandemic are discussed in the report.

End user assessment

The report branches off the automated drug preparation system the global market based on different end-users. The supply-demand ratio and consumption volume of each end user are accurately described in the report.

To reveal the competitive landscape of Automated Drug Preparation System, global market:

  • The global Automated Drug Preparation System market report comprises a holistic competitive analysis of this business scenario. According to the report, organizations BD, Baxter International, TOSHO, Takazono, Omnicell, YUYAMA, Swisslog, Willach Group, Innovation, Parata, TCGRx, ScriptPro, Talyst, Cerner, Kirby Lester, etc. are included in the competitive landscape of the market.
  • The information regarding the production facilities owned by major industry players, market share and respective regions operated are appropriately described in the report.
  • The study combines information on the manufacturer’s product portfolio, major product applications and product specifications.
  • The pricing models and gross margins of the major competitors in the market are also outlined in the research report.

Other Findings From The Study That Will Influence The Revenue Generation Of Automated Drug Preparation System, Global Market:

  • Global Automated Drug Preparation System market research report examines the product line of this vertical in complete details. Based on the research, the automated drug preparation system, the global market according to the product landscape is divided into Semi-automatic and fully automatic.
  • Information on the industry share acquired by each type of product, profit assessment and production growth rate are also included in the research report.
  • The report covers a complex study of the application spectrum of the market which has been fragmented into Hospital pharmacy, Ambulatory pharmacy, Retail pharmacy and others.
  • Information about the industry share of each application, the estimates of the product demand on the basis of each application, and the growth rate of the applications in the following years, has been included in the Automated Drug Preparation System. , global market report.
  • Other major factors such as raw material processing rate and market concentration rate are described in the study.
  • The study analyzes current market price trends and expected growth drivers for the industry.
  • An overview of trends in marketing channel development, marketing approach and market positioning is discussed in the research report.
  • The study also reveals information regarding producers and distributors, manufacturing cost structure, and downstream buyers of the global Automated Drug Preparation System market.

Important questions answered in the report:

  1. Which company is expected to dominate the global automated drug preparation systems market in terms of market share in 2020?
  2. What has been the impact of the changing regulatory framework on the growth of the global automated drug preparation system market?
  3. Which application of the automated drug preparation system, Global is expected to generate the maximum revenue during the forecast period?
  4. How is the COVID-19 pandemic likely to impact the growth trajectory of the Automated Drug Preparation System Market, global?
  5. How do market players adapt to fluctuations in the prices of key raw materials?

Key Findings of Automated Drug Preparation System, Global Market Report:

  • Impact of technological innovations on the automated drug preparation system, global market
  • Growth strategies adopted by the main market players to meet the major challenges posed by the COVID-19 pandemic
  • Historical and current trends that may impact the dynamics of Automated Drug Preparation System, global market
  • Assessment of the growth of various market segments during the forecast period
  • Regional and Global Presence of Important Market Players in Automated Drug Preparation System, Global Market

Request customization on this report @

Source link

]]> 0
Effectiveness and instructions for use Thu, 23 Sep 2021 22:23:22 +0000

There is no cure for psoriasis, but some over-the-counter (OTC) treatments can relieve itching, dander, or uncomfortable skin.

OTC products are often sold online or in stores without a doctor’s prescription. They come in different formulations, such as:

  • lotions
  • creams
  • gels
  • oils
  • foams
  • tars
  • bath solutions
  • shampoos

In this article, we take a look at the most commonly used over-the-counter products for psoriasis and how they work to help relieve symptoms.

Over-the-counter topicals containing salicylic acid, an exfoliating agent, are commonly used to treat symptoms of psoriasis. This ingredient has been approved by the Food and Drug Administration (FDA) for the treatment of psoriasis. It works by causing the outer layer of the skin to peel off, which helps reduce flaking and swelling.

It is important to use salicylic acid as directed, as too much acid can cause irritation and make your condition worse.

Tar is another ingredient approved by the FDA to treat psoriasis. It comes from charcoal and wood and can slow the growth of skin cells. Many people report smoother skin with less flaking, itching, and inflammation.

Coal tar products can irritate your skin and make it more sensitive to the sun. You should use sunscreen when you are outside. Additionally, some studies have shown that very high amounts of coal tar, such as those used in industrial paving, are linked to cancer. You may want to talk to your doctor about this risk.

Keeping your skin hydrated and hydrated can help relieve redness and itching. Thick creams or ointments that trap water are preferred. They relieve dryness and help your skin heal.

You can even use shortening or coconut oil to keep your skin lubricated.

Some over-the-counter bath products help remove dander and soothe irritated skin. To create your own solution, add one of the following to your bath:

Try to soak for about 15 minutes.

OTC scale lifters, also known as keratolytics, typically contain ingredients such as:

Products containing these ingredients help loosen and remove dander, which allows drugs to reach psoriasis plaques. It may be helpful to take a 15-minute hot bath before using a scale lifter.

Occlusion refers to covering the skin so that it can better absorb topical medications or moisturizers. You can cover the area with:

  • cellophane
  • Plastic wrap
  • waterproof dressings
  • cotton socks
  • a nylon suit

Talk to your doctor about this method before using it. It is important to know which topical treatments can be used safely under skin.

Over-the-counter anti-itch products may contain the following ingredients:

These medications can help relieve itching caused by psoriasis, but they can also irritate and dry out your skin.

Other over-the-counter treatments that can soothe your skin and relieve itching may include the following:

Although some of these ingredients have not been proven to work, many people with psoriasis report relief anecdotally.

Some over-the-counter treatments can irritate or dry out your skin. You can use moisturizer with them to counter this effect.

It may also be helpful to test the products on a small area of ​​the skin first to see how you respond to the treatment. Some topical medications can be applied over moisturizer to minimize side effects.

Treatments containing coal tar can stain clothing or bed linens, so you may want to protect these items with a towel or other barrier.

It is also important to know that the concentration of ingredients can vary by brand and product. As a rule, the higher the concentration, the more potent the drug.

Several over-the-counter products are available to help treat the symptoms of psoriasis. Although many of them offer relief, it is best to consult a doctor before using any new treatment for your condition.

If these treatments don’t work, your doctor may recommend a prescription medication that may better relieve your symptoms.

Source link

]]> 0
Cameroon: MINDEF – Medicines given to Joint Military Regions Thu, 23 Sep 2021 07:27:01 +0000

Defense Minister Joseph Beti Assomo presided over the launch ceremony for the distribution of drugs and medical supplies.

The government of Cameroon through the Ministry of Defense has benefited from the donation of a large batch of drugs and medical supplies by the Mark Foundation International USA and International Relief Teams USA.

The donation was facilitated by the Limona International Cameroon Foundation whose co-founder and Country Director, Nfinyo T. Mabu represented the two donor organizations during the ceremony to launch the distribution of drugs to the Headquarters Brigade in Yaoundé on the 21st September 2021.

The donation is intended to save the health situation of soldiers and the population, mainly refugees, women, children and other vulnerable people in areas affected by conflicts and security crises. These regions include the Far North region which faces Boko Haram insurgents, the East region which faces security threats and a large number of refugees due to insecurity in the Central African Republic and the people displaced within the socio-political crisis in the South West and the North. Western regions. A series of diseases are targeted including HIV, the Covid-19 pandemic and the distribution of drugs will be free.

The Minister Delegate to the Presidency in charge of Defense Joseph Beti Assomo while presiding over the launching ceremony of the distribution of drugs and medical supplies to the Headquarters Brigade in Yaoundé on September 21, 2021 praised the patriotism of Nfinyo Mabu for have stepped up advocacy for the country to benefit from aid. He recalled that Cameroon had been facing security challenges for some time and that the Covid-19 pandemic was added to it. The donation, specified the Minister, constitutes a strategic partnership between MINDEF and donor organizations which will allow the defense and security forces to intensify their civil-military actions on the ground, thus consolidating the link with the population. The Minister called for its rapid and transparent distribution.